If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 317.00
Bid: 274.00
Ask: 320.00
Change: 0.00 (0.00%)
Spread: 46.00 (16.788%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 317.00
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful disposal of shares in Permanent TSB

2 Jun 2023 07:00

RNS Number : 4239B
NatWest Group plc
02 June 2023
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SWITZERLAND OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT

 

NatWest Group plc

2 June 2023

 

Successful disposal of shares in Permanent TSB Group Holdings PLC

 

Further to the announcement on 1 June 2023, NatWest Group plc ("NatWest") announces the successful completion of the disposal of part of its shareholding, held through the wholly owned subsidiary RBS AA Holdings (UK) Limited, in Permanent TSB Group Holdings PLC ("PTSB"). 

The overall size of the disposal by the Minister for Finance of Ireland and NatWest (the "Selling Shareholders") was 54.6 million ordinary shares in PTSB representing 10.0% of the ordinary share capital of PTSB, with NatWest disposing of 27.3 million ordinary shares in PTSB representing 5.0% of the ordinary share capital of PTSB. The disposal was effected by way of a placing (the "Placing") of shares (the "Placing Shares") in an accelerated book building process.

In summary, following settlement of the Placing which will take place on 6 June 2023:

· The shareholding of NatWest will be reduced from 90.9 million ordinary shares, representing approximately 16.7% of the ordinary share capital of PTSB, to 63.6 million ordinary shares, representing approximately 11.7% of the ordinary share capital of PTSB.

· The Placing price was €2.025 per share. As a result, the overall gross proceeds from the sale of the Placing Shares will be €110.5 million, with both Selling Shareholders receiving €55.2 million of gross proceeds each.

· The disposal will have an immaterial impact on NatWest's CET1 ratio and its TNAV per share.

· The Selling Shareholders have undertaken not to sell further shares in PTSB for a period of 90 calendar days following the completion of the Placing (subject to waiver by one of the co-bookrunners and certain customary exceptions).

 

NatWest CEO Alison Rose said: 

"This transaction represents further positive progress on our phased withdrawal from the Republic of Ireland."

NatWest will keep further disposal options under active consideration, as and when market conditions permit.

 

 

Further information:

 

 

Investor Relations

+ 44 (0)207 672 1758

 

Media Relations

+44 (0)131 523 4205

 

 

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

Disclosure

 

IMPORTANT INFORMATION

 

This announcement is for information purposes only and does not constitute an offer or an invitation to acquire or dispose of any securities of PTSB in the United States, Canada, Australia or Japan or in any other jurisdiction in which such an offer of solicitation is unlawful. The shares sold pursuant to the Placing have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under any securities laws of any state or jurisdiction of the United States and may not be offered or sold in the United States absent registration or an exemption from registration. There was no public offering of securities in the United States.

 

Neither this announcement nor any copy of it may be taken, transmitted or distributed, directly or indirectly in or into Australia, Canada, Japan, The Republic of South Africa, Switzerland or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction. Any failure to comply with this restriction may constitute a violation of the securities laws of any such jurisdiction.

 

In member states of the European Economic Area, this announcement and any offer if made subsequently is directed exclusively at persons who are 'qualified investors' within the meaning of Regulation (EU) 2017/1129 (the "Prospectus Regulation") ("Qualified Investors"). In the United Kingdom this announcement is directed exclusively at persons who are 'qualified investors' within the meaning of the Prospectus Regulation (as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018) (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) who fall within Article 49(2)(a) to (d) of the Order, or (iii) to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). This Announcement must not be acted on or relied on by persons who are not Relevant Persons, if in the United Kingdom, or Qualified Investors, if in a member state of the European Economic Area.

 

No Placing Shares will be available to any investor whose purchase of such Placing Shares, whether on its own account or as a fiduciary or agent for one or more investor accounts, would require regulatory consent in any jurisdiction (including, without limitation, under the UK Financial Services and Markets Act 2000 or the United States Bank Holding Company Act of 1956).

 

 

Forward-looking statements

 

This document may include forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'expect', 'estimate', 'project', 'anticipate', 'commit', 'believe', 'should', 'intend', 'will', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'may', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as NatWest's future economic results, business plans and strategies. In particular, this document may include forward-looking statements relating to NatWest in respect of, but not limited to: its economic and political risks, its regulatory capital position and related requirements, its financial position, profitability and financial performance (including financial, capital, cost savings and operational targets), the implementation of its purpose-led strategy, its environmental, social and governance and climate related targets, its access to adequate sources of liquidity and funding, increasing competition from new incumbents and disruptive technologies, its exposure to third party risks, its ongoing compliance with the UK ring-fencing regime and ensuring operational continuity in resolution, its impairment losses and credit exposures under certain specified scenarios, substantial regulation and oversight, ongoing legal, regulatory and governmental actions and investigations, the transition of LIBOR and IBOR rates to replacement risk free rates and NatWest's exposure to operational risk, conduct risk, cyber, data and IT risk, financial crime risk, key person risk and credit rating risk. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, future growth initiatives (including acquisitions, joint ventures and strategic partnerships), the outcome of legal, regulatory and governmental actions and investigations, the level and extent of future impairments and write-downs, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations, general economic and political conditions and the impact of climate-related risks and the transitioning to a net zero economy. These and other factors, risks and uncertainties that may impact any forward-looking statement or NatWest's actual results are discussed in NatWest's 2022 Annual Report on Form 20-F, NatWest's Interim Management Statement for Q1 2023 on Form 6-K and its other filings with the US Securities and Exchange Commission. The forward-looking statements contained in this document speak only as of the date of this document and NatWest does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSSMEFFEDSEDM
Date   Source Headline
23rd Nov 20224:08 pmRNSDividend Declaration
11th Nov 20227:00 amRNSQ3 2022 Pillar 3 Supplements
10th Nov 20223:53 pmRNSDirector/PDMR Shareholding
8th Nov 20224:55 pmRNSHolding(s) in Company
7th Nov 20227:30 amRNSUlster Bank Retail Business: Acquisition Completed
4th Nov 202211:19 amRNSPricing of USD 7.472% Senior Callable Notes
31st Oct 20223:35 pmRNSTotal Voting Rights
28th Oct 20225:52 pmRNSPublication of Suppl.Prospcts
28th Oct 20227:00 amRNSNWG Q3 IMS Interim Management Statement 2022
20th Oct 20229:00 amRNSNatWest and Vodeno Create Strategic Partnership
5th Oct 20221:51 pmRNSBlock listing six monthly return
30th Sep 20222:15 pmRNSDirectorate Change
30th Sep 202212:45 pmRNSTotal Voting Rights
26th Sep 20225:44 pmRNSPublication of Suppl.Prospcts
26th Sep 20223:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20225:25 pmRNSChanges to our Board
23rd Sep 202212:30 pmRNSNatWest Group notes rating actions by Moody's
20th Sep 20229:30 amRNSTR-1: Notification of Major Holdings
20th Sep 20228:00 amRNSBank of America Annual Financials CEO Conference
13th Sep 20228:30 amRNSBarclays Global Financial Services Conference
8th Sep 20222:00 pmRNSDirector/PDMR Shareholding
5th Sep 202211:18 amRNSAdam & Company Private Banking Business
2nd Sep 20222:43 pmRNSPublication of Final Terms - Replacement
2nd Sep 20221:44 pmRNSPublication of Final Terms
31st Aug 20226:23 pmRNSAdjustment to conversion prices for NWG's AT1s
31st Aug 20222:34 pmRNSTotal Voting Rights
30th Aug 20228:10 amRNSShare consolidation and total voting rights
25th Aug 20224:32 pmRNSResult of General Meeting and Class Meeting
25th Aug 20222:00 pmRNSGeneral Meeting and Class Meeting Statement
12th Aug 20222:23 pmRNSUpdate to Financial Impact of Tender Offers
12th Aug 20227:00 amRNSH1 2022 Pillar 3 Supplements
11th Aug 202210:15 amRNSHolding(s) in Company
10th Aug 20226:18 pmRNSFinancial Impact of Tender Offers
10th Aug 20224:30 pmRNSDirector/PDMR Shareholding
9th Aug 20226:26 pmRNSResults of Tender Offers
9th Aug 202211:08 amRNSPricing of Tender Offers
9th Aug 20227:00 amRNSNotice of General Meeting and Class Meeting
1st Aug 20225:02 pmRNSTender Offer
1st Aug 20224:32 pmRNSPublication of Final Terms
29th Jul 20224:59 pmRNSPublication of Supplementary Prospectus
29th Jul 20223:19 pmRNSTotal Voting Rights
29th Jul 20227:00 amRNSInterim Results - NatWest Markets N.V.
29th Jul 20227:00 amRNSInterim Results - NatWest Group (Part 2 of 2)
29th Jul 20227:00 amRNSInterim Results - NatWest Group (Part 1 of 2)
22nd Jul 20228:01 amRNSCompetition clearance received on Ulster Bank deal
15th Jul 20226:05 pmRNSTransaction in Own Shares
14th Jul 20225:21 pmRNSTransaction in Own Shares
13th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20225:14 pmRNSTransaction in Own Shares
11th Jul 20225:21 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.